SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001798749-23-000045
Filing Date
2023-06-21
Accepted
2023-06-21 17:14:03
Documents
12
Period of Report
2023-06-21
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20230621x8k.htm   iXBRL 8-K 42874
  Complete submission text file 0001798749-23-000045.txt   168031

Data Files

Seq Description Document Type Size
2 EX-101.SCH tmb-20230621.xsd EX-101.SCH 3124
3 EX-101.LAB tmb-20230621_lab.xml EX-101.LAB 16578
4 EX-101.PRE tmb-20230621_pre.xml EX-101.PRE 10780
6 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20230621x8k_htm.xml XML 5040
Mailing Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451
Business Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451 617-443-2400
Aerovate Therapeutics, Inc. (Filer) CIK: 0001798749 (see all company filings)

IRS No.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40544 | Film No.: 231030798
SIC: 2834 Pharmaceutical Preparations